Orange Book product · Generic (ANDA)
CALCITONIN-SALMON
CALCITONIN SALMON
At a glance
Nov 10, 2021
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 10, 2021
4 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
CALCITONIN SALMON
Strength
200 IU/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 209358
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CALCITONIN SALMON
- 1995MIACALCINBrand (NDA)
NDA 020313 · PHARMOBEDIENT
- 1986MIACALCINBrand (NDA)
NDA 017808 · MYLAN IRELAND LTD
- —CALCIMARBrand (NDA)
NDA 017769 · SANOFI AVENTIS US
- —CALCIMARBrand (NDA)
NDA 017497 · SANOFI AVENTIS US
- 2026CALCITONIN-SALMONGeneric (ANDA)
ANDA 215864 · ZYDUS PHARMS
- 2025CALCITONIN-SALMONGeneric (ANDA)
ANDA 216294 · AMNEAL
- 2025CALCITONIN-SALMONGeneric (ANDA)
ANDA 219196 · SAGENT
- 2024CALCITONIN-SALMONGeneric (ANDA)
ANDA 212675 · FRESENIUS KABI USA
- 2024CALCITONIN-SALMONGeneric (ANDA)
ANDA 213766 · CIPLA
- 2024CALCITONIN-SALMONGeneric (ANDA)
ANDA 215715 · DR REDDYS
- 2021CALCITONIN-SALMONGeneric (ANDA)
ANDA 212416 · CUSTOPHARM INC
- 2009CALCITONIN-SALMONGeneric (ANDA)
ANDA 076979 · PH HEALTH
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
